Baudax Bio Announces Date of Reconvened Special Meeting
Special Meeting to be reconvened on August 11, 2021 solely with respect to Proposal 1
MALVERN, Pa., July 30, 2021 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX) (the Company), a pharmaceutical company focused on commercializing and developing innovative…
